Abstract

Flashback Foreword: Erlotinib and Gemcitabine in Pancreatic Cancer.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Do anti-stroma therapies improve extrinsic resistance to increase the efficacy of gemcitabine in pancreatic cancer?
Chen Liang ... Quanxing Ni
Cellular and molecular life sciences : CMLS | VOL. 75
Chen Liang, et. al.Chen Liang ... Quanxing Ni
09 Oct 2017
The Antitumor Activity of Sodium Selenite Alone and in Combination with Gemcitabine in Pancreatic Cancer: An In Vitro and In Vivo Study.
Kevin Doello ... Laura Cabeza
Cancers | VOL. 13
Kevin Doello, et. al.Kevin Doello ... Laura Cabeza
25 Jun 2021
Glycogen synthase kinase-3β participates in acquired resistance to gemcitabine in pancreatic cancer.
Masahiro Uehara ... Osamu Takeuchi
Japanese journal of cancer research : Gann | VOL. 111
Masahiro Uehara, et. al.Masahiro Uehara ... Osamu Takeuchi
12 Oct 2020
WT1 associated protein promotes metastasis and chemo-resistance to gemcitabine by stabilizing Fak mRNA in pancreatic cancer
Bing-Qi Li ... Yu-Pei Zhao
Cancer Letters | VOL. 451
Bing-Qi Li, et. al.Bing-Qi Li ... Yu-Pei Zhao
06 Mar 2019
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Leptomeningeal Metastasis in the Era of CNS-Penetrant Tyrosine Kinase Inhibitor Therapy.
Mark Y Jeng ... Helena A Yu
Journal of Clinical Oncology | VOL. 42
Mark Y Jeng, et. al.Mark Y Jeng ... Helena A Yu
10 Aug 2024
Management of Locally Advanced Rectal Cancer: ASCO Guideline.
Aaron J Scott ... Sepideh Gholami
Journal of Clinical Oncology | VOL. -
Aaron J Scott, et. al.Aaron J Scott ... Sepideh Gholami
08 Aug 2024
Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201.
Jordan R Hansford ... Eric Bouffet
Journal of Clinical Oncology | VOL. -
Jordan R Hansford, et. al.Jordan R Hansford ... Eric Bouffet
07 Aug 2024
Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials.
Rik J Verheijden ... Karijn P M Suijkerbuijk
Journal of Clinical Oncology | VOL. -
Rik J Verheijden, et. al.Rik J Verheijden ... Karijn P M Suijkerbuijk
07 Aug 2024
View more papers